The investigation determined that a non-reproducible, higher than expected ck-mb result was obtained from a single patient sample using vitros ck-mb reagent with a vitros eci immunodiagnostic system.The definitive assignable cause could not be determined.An instrument issue could not be ruled out as contributing to the event as an assessment of the system has yet to be performed.Historical quality control data was not provided and therefore a vitros ck-mb lot 1850 performance issue could also not be ruled out as a contributing factor.Ortho determined that the customer was not following the sample collection device manufacturer¿s recommendations for sample centrifugation, so pre-analytical sample handling could not be ruled out as contributing to the event.It is likely that cellular debris, due to poor sample preparation, was present in the affected sample, although this could not be confirmed.
|
A customer obtained a non-reproducible, higher than expected creatine kinase-mb (ck-mb) result from a single patient sample (ck-mb = 3.32 ng/ml vs.Expected result of 2.04 ng/ml) using vitros ck-mb reagent with a vitros eci immunodiagnostic system.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The higher than expected ck-mb result was reported from the laboratory, however, there was no allegation of patient harm as a result of the event.(b)(4).
|